SASandeep Arora

Sandeep Arora

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sandeep Arora has a total of 36 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • General Principle, Procedures and Detectors of X‐Ray Fluorescence

    by Rakesh K. Sindhu, Shantanu K. Yadav, Mansi Chitkara, Inderjeet S. Sandhu, Sandeep Arora, Inderjeet Verma, Evren Algın Yapar, Vivek Kumar Singh


  • Exploring the effect of Crinum latifolia in obesity: possible role of oxidative, angiogenic, and inflammatory pathways

    by Priya Nijhawan, Tapan Behl, Sridevi Chigurupati, Aayush Sehgal, Sukhbir Singh, Neelam Sharma, Aditi Sharma, Amira Saber Ahmed, Suprava Das, Vasanth Raj Palnimuthu, et al.

    Obesity is a multifaceted disease encompassing deposition of an unnecessary amount of fat which upsurges the possibility of other complications, viz., hypertension and certain type of cancers. Although obesity results from combination of genetic factors, improper diet and inadequate physical exercise also play a major role in its onset. The present study aims at exploring the anti-obesity activity of Crinum latifolia leaf extract in obese rats. The leaves were extracted using hydroalcoholic extraction which was later diluted with water and given to obese rats. The dosing was started from the 4th week (by oral administration of extract of Crinum latifolia (100 mg/kg and 200 mg/kg) and combination of Crinum latifolia leaf extract 200 mg/kg and orlistat 30 mg/kg) till the 10th week. Various angiogenic, antioxidant, biochemical, and inflammatory biomarkers were assessed at the end of the study. The obese symptoms were progressively reduced in treatment groups when compared to disease control groups. The angiogenic parameters and inflammatory parameters were consequently reduced in treatment groups. The oxidative parameters superoxide dismutase (SOD) and catalase were gradually increased, while levels of TBARS were reduced in treatment groups showing antioxidant nature of leaf hydroalcoholic extract. The Crinum latifolia leaf extract possesses anti-obesity properties and therefore can be used as a therapeutic option in the management of obesity.


  • Understanding The Role of Inflammasome in Angina Pectoris

    by Ishita Sharma, Tapan Behl, Simona Bungau, Monika Sachdeva, Arun Kumar, Gokhan Zengin, Sandeep Arora

    Angina pectoris, associated with coronary artery disease, a cardiovascular disease where the pain is caused by adverse oxygen supply in the myocardium, results in contractility and discomfort in the chest. Inflammasomes, triggered by stimuli due to infection and cellular stress, have been identified to play a vital role in the progression of cardiovascular disorders and, thus, causing various symptoms like angina pectoris. Nlrp3 inflammasome, a key contributor in the pathogenesis of angina pectoris, requires activation and primary signaling for the commencement of inflammation. Nlrp3 inflammasome elicits out an inflammatory response by the emission of pro-inflammatory cytokines by ROS (reactive oxygen species) production, mobilization of K+ efflux and Ca2+ and by activation of lysosome destabilization that eventually causes pyroptosis, a programmed cell death process. Thus, inflammasome is considered to be one of the factors involved in the progression of coronary artery diseases and has an intricate role in the development of angina pectoris.


  • Natural Fused Heterocyclic Flavonoids: Potent Candidates as Anti- Inflammatory and Anti-Allergic Agents in the Treatment of Asthma

    by Rajwinder Kaur, Kirandeep Kaur, Rashmi Arora, Balraj Saini, Sandeep Arora

    Background: In the last two decades, the flavonoids containing fused heterocyclic nucleus in their chemical structure have emerged to display a variety of pharmacological effects including antiallergic and anti-inflammatory the most recent to the list. These polyphenolic compounds exert their pharmacological effect by various mechanisms including inhibition of human neutrophil elastase, cytokines (Interleukins- IL-3 and IL-4) and mast cells. Methods: We adopted a structured search of notorious journal publication websites and electronic databases such as Science Direct, Bentham, Scopus, PubMed, Nature, Springer etc. for the collection of peer-reviewed research and review articles for the present review. The quality papers (109) were retrieved, studied, categorized into different sections, analyzed and used for article writing. Results: The backbone of this review article is based on four review articles of natural phenolics. Seventeen papers out of total one hundred and nine were about Quercetin the main molecule of interest, five papers outlined the potential benefits of Pycnogenol, Rutin was discussed in detail by considering eight papers in mind, Kaempferol which can be considered as a candidate of interest was referred from six articles. Conclusion: This review identified the Quercetin, Pycnogenol, Rutin and Kampferol as few bioflavonols out of hundreds of other compounds still under clinical trials that have been studied most. Marketed formulations of Pycnogenol are also available as nutraceuticals. These flavonoids have been also reported to the other pharmacological effects like anti-cancer, anti-oxidants, anti-hypertensive, antiviral, anti-ulcerogenic, anti-platelet, anti-hypotensive and anti-hepatotoxic. With all these versatile properties heterocyclic containing flavonoids may be a powerful candidate for the discovery of their utilization in other ailments like asthma.


  • Development of Bilayer Tablet Containing Saxagliptin Immediate Release and Metformin Sustained Release Using Quality by Design Approach

    by Amit Kaushal, Sandeep Arora, Neelam Sharma, Sukhbir Singh

    Objective: Adequate glycemic control in diabetes patients requires oral combination therapy. Saxagliptin is a dipeptidyl peptidase-4 inhibitor having fewer adverse effects, and metformin is the first-line medicine for diabetes treatment. The aim of this research work is to develop a bilayer tablet of saxagliptin and metformin in fixed-dose combination (FDC) using quality by design (QbD) to acquire the immediate release of saxagliptin and sustained release of metformin from bilayer tablet to ultimately achieve superior patient compliance. Methods: The development of the bilayer tablet was done in four stages using QbD. In the first step, quality target product profile (QTPP) of bilayer tablet was defined, and critical quality attributes (CQAs) were identified by risk estimation matrix and taguchi design; an immediate release saxagliptin layer was optimized in the second step, optimization of sustained-release metformin layer was carried out in the third step, and in the final step, bilayer tablet was prepared and characterized. The effect of independent parameters, i.e., magnesium stearate level (X-1), kneading time (X-2) and lubrication time (X-3) on Carr's Index (Y-1), percentage relative standard deviation of content uniformity (Y-2) and drug release at 30 minutes (Y-3), were estimated for optimization of immediate release saxagliptin layer using Box-Behnken design (BBD). The effect of independent parameters, i.e., hydroxypropyl methylcellulose level (X-4), compritol level (X-5) and magnesium stearate level (X-6) on Carr's Index (Y-4), drug release at 2 h (Y-5), drug release at 5 h (Y-6) and drug release at 10 h (Y-7) were estimated for optimization of sustained-release metformin layer using BBD. Results: The optimized composition of immediate release saxagliptin layer estimated using numerical optimization by Design expert was 0.88% (X-1), 15 minutes (X-2) and 3.85 minutes (X-3) with predicted variables, i.e., 10.59% (Y-1), 3.16% (Y-2) and 85% (Y-3). The optimized composition of sustained-release saxagliptin layer predicted through numerical optimization was 30% (X-4), 3.36% (X-5) and 0.9% (X-6) having 10.89% (Y-4), 43.44% (Y-5), 60% (Y-6) and 85.14% (Y-7). In-vitro dissolution study of bilayer tablet showed immediate release of Saxagliptin (approximately 85% in 30 minutes) and sustained release of metformin illustrating 43.21 +/- 1.21, 60.86 +/- 2.96 and 86.26 +/- 1.38% drug release at 2, 5 and 10 h, respectively. The release exponent for the Korsmeyer-Peppas model for Saxagliptin and metformin was 0.237 (0.85), indicating Fickian and super case II transport drug release behavior, respectively. Conclusion: By QbD approach, bilayer tablet containing saxagliptin and metformin was successfully developed, and influence of various formulation parameters on CQAs of drug products was understood with fewer experiments. This leads to the conclusion that cost can be reduced using QbD in the development of FDC for improving patient compliance.


  • Open Access

    Discovery and development of multi‐target potential of flavonoids as potent acetylcholinesterase inhibitors and anti‐amnestic agents

    by Manjinder Singh, Sandeep Arora, Om Silakari

    Background: Multi‐target compounds comprise a novel class of therapeutic agents for the treatment of multi‐factorial diseases like Alzheimer’s disease (AD). Following this approach, a new series of flavones were designed, synthesized and biologically evaluated against acetylcholinesterase (AChE), advanced glycation end products formation (AGEs) with additional free radical scavenging activity.Method: On the basis of proposed hypothesis, 33 flavone derivatives were designed and subsequently synthesized and were primarily evaluated for in vitro AChE inhibitory, AGEs inhibitory and anti‐oxidative activity and prominent compounds further evaluated by in vivo anti‐amnestic activity. After that, molecular docking and Molecular dynamic simulations (MD) were carried out for the most potent compounds to study protein‐ligand interactions.Result: The in vitro studies showed that the majority of synthesized derivatives inhibited acetylcholinesterase (AChE) with IC50 values in the nanomolar range. Additionally, these compounds also exhibited greater ability to inhibit advanced glycation end products formation in micromolar range with additional radical scavenging property in nanomolar range. The most active compounds were also ameliorated scopolamine‐induced amnesia in mice in terms of restoration of time spent in target quadrant (TSTQ) and escape latency time (ELT). Moreover, the molecular docking study displayed that most potent compounds simultaneously bind to catalytic active site (CAS) and peripheral anionic site (PAS) of AChE.Conclusion: In conclusions, the results support the proposed hypothesis that newly designed multi‐target flavones have the ability to act on different targets or exhibit multiple pharmacological activities related to Alzheimer’s disease. Thus, flavones might be the promising lead compound as potential multi‐target anti‐Alzheimer’s agents.


  • Top Cited Papers

    Nitrogen-Containing Heterocycles as Anticancer Agents: An Overview

    by Damanpreet K. Lang, Rajwinder Kaur, Rashmi Arora, Balraj Saini, Sandeep Arora

    Background: Cancer is spreading all over the world, and it is becoming the leading cause of major deaths. Today’s most difficult task for every researcher is to invent a new drug that can treat cancer with minimal side effects. Many factors, including pollution, modern lifestyle and food habits, exposure to oncogenic agents or radiations, enhanced industrialization, etc. can cause cancer. Treatment of cancer is done by various methods that include chemotherapy, radiotherapy, surgery and immunotherapy in combination or singly along with kinase inhibitors. Most of the anti-cancer drugs use the concept of kinase inhibition. Objective: The number of drugs being used in chemotherapy has heterocycles as their basic structure in spite of various side effects. Medicinal chemists are focusing on nitrogen-containing heterocyclic compounds like pyrrole, pyrrolidine, pyridine, imidazole, pyrimidines, pyrazole, indole, quinoline, oxadiazole, azole, benzimidazole, etc. as the key building blocks to develop active biological compounds. The aim of this study is to attempt to compile a dataset of nitrogen-containing heterocyclic anti-cancer drugs. Methods: We adopted a structural search on notorious journal publication websites and electronic databases such as Bentham Science, Science Direct, PubMed, Scopus, USFDA, etc. for the collection of peer-reviewed research and review articles for the present review. The quality papers were retrieved, studied, categorized into different sections, analyzed and used for article writing. Conclusion: As per FDA databases, nitrogen-based heterocycles in the drug design are almost 60% of unique small-molecule drugs. Some of the nitrogen-containing heterocyclic anti-cancer drugs are Axitinib, Bosutinib, Cediranib, Dasatanib (Sprycel®), Erlotinib (Tarceva®), Gefitinib (Iressa®), Imatinib (Gleevec®), Lapatinib (Tykerb ®), Linifanib, Sorafenib (Nexavar®), Sunitinib (Sutent®), Tivozanib, etc. In the present review, we shall focus on the overview of nitrogen-containing heterocyclic active compounds as anti-cancer agents.


  • Molecular Hybrids of N-Phthaloylglycyl Hydrazide and Hydrazinecarbothioamide with Anti-inflammatory and Anti-oxidant Activities

    by Ankur Gera, Chander Mohan, Jitender Madan, Sandeep Arora

    Background: Oxidative stress due to high levels of reactive organic species is the cause of the progression of inflammation in various diseases. The molecules possessing both anti-inflammatory and antioxidant activity can be the promising key to treat inflammatory diseases. Phthalimide and hydrazinecarbothioamide are anti-inflammatory and anti-oxidant pharmacophores.Objective: Molecular hybrids possessing above two pharmacophores were designed. A series of N-phenyl substituted 2-(2-(1,3-dioxoisoindolin-2-yl)acetyl)-N-phenylhydrazine-1-carbothioamide (CGS compounds) was synthesized and evaluated for biological activities.Methods: N-phthaloylglycyl hydrazide was reacted with unsubstituted/substituted phenyl isothiocyanates to yield CGS compounds. Synthesized compounds were evaluated for in vivo anti-inflammatory activity in carrageenan rat paw edema model, and in vitro anti-oxidant activity by DPPH assay. Levels of TNF-α and oxidative stress at the site of inflammation were measured. The genetic algorithm-PLS regression based QSAR model correlating the effect of N-phenyl substituent on the anti-inflammatory activity was developed. Further, the interaction of the active compound in the TNF-α binding pocket was studied by in silico docking.Results: Compound containing the 2-OCH3, 4-NO2 (CGS-5); 4-CF3 (CGS-9); 4-NO2 (CGS-3) showed significant anti-inflammatory activity (percentage inhibition of paw edema after 3 hour = 58.24, 50.38, 40.05, respectively) and potent anti-oxidant activity (IC50 =0.045, 0.998, 0.285 μg/ml, respectively). Reduced levels of TNF- α and increased levels of GSH were observed for the above three compounds. Descriptors for QSAR model identified by GA-PLS were WPSA1, Weta1unity, WDunity, SC3, VC5, MlogP, and WTPT3. The identified model was highly predictive, and value of root mean square error of prediction for internal (leave one out) and external validation was: 1.579, 1.325.Conclusion: Molecular hybrids of phthalimide and hydrazinecarbothioamide were synthesized. Some of the compounds possessed promising anti-inflammatory and anti-oxidant activities.